CD274 and neoplasm: We then created MC-38HuPD-L1 cells in which the mouse PD-L1 sequence was removed and replaced by the human PD-L1 sequence, thus making both the host and tumor cells a fully humanized PD-1/L1 system ideal for testing the FDA-approved therapies (Fig. 3A).